[go: up one dir, main page]

WO2001052817A3 - Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles - Google Patents

Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles Download PDF

Info

Publication number
WO2001052817A3
WO2001052817A3 PCT/US2001/002299 US0102299W WO0152817A3 WO 2001052817 A3 WO2001052817 A3 WO 2001052817A3 US 0102299 W US0102299 W US 0102299W WO 0152817 A3 WO0152817 A3 WO 0152817A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically relevant
cochleate
relevant molecules
delivering biologically
cochleates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/002299
Other languages
English (en)
Other versions
WO2001052817A2 (fr
Inventor
Leila Zarif
Tuo Jin
Ignacio Segarra
Raphael J Mannino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Biodelivery Sciences Inc
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Biodelivery Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/001684 external-priority patent/WO2000042989A2/fr
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey, Biodelivery Sciences Inc filed Critical University of Medicine and Dentistry of New Jersey
Priority to EP01903273A priority Critical patent/EP1259224A2/fr
Priority to CA002397792A priority patent/CA2397792A1/fr
Priority to AU31114/01A priority patent/AU3111401A/en
Priority to JP2001552865A priority patent/JP2003529557A/ja
Publication of WO2001052817A2 publication Critical patent/WO2001052817A2/fr
Publication of WO2001052817A3 publication Critical patent/WO2001052817A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne un procédé de production d'une structure cochléaire de petite taille à base de lipide. Les structures cochléaires sont obtenues à partir de liposomes qui sont mis en suspension dans une solution aqueuse polymère à deux phases, ce qui permet de séparer de manière différentielle les structures à base de molécules polaires par séparation de phases. La solution polymère à deux phases contenant des liposomes, traitée à l'aide de molécules chargées positivement telles que Ca?2+ ou Zn2+¿, forme un précipité de structures cochléaires présentant des dimensions de particules inférieures à un micron. Le procédé peut être utilisé pour produire des structures cochléaires contenant des molécules biologiquement utiles.
PCT/US2001/002299 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles Ceased WO2001052817A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01903273A EP1259224A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
CA002397792A CA2397792A1 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
AU31114/01A AU3111401A (en) 2000-01-24 2001-01-24 New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
JP2001552865A JP2003529557A (ja) 2000-01-24 2001-01-24 コクリエート製剤、その調製方法および生物学的関連分子投与のための用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2000/001684 WO2000042989A2 (fr) 1999-01-22 2000-01-24 Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles
USPCT/US00/01684 2000-01-24
US09/613,840 2000-07-11
US09/613,840 US6592894B1 (en) 1999-01-22 2000-07-11 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules

Publications (2)

Publication Number Publication Date
WO2001052817A2 WO2001052817A2 (fr) 2001-07-26
WO2001052817A3 true WO2001052817A3 (fr) 2002-02-21

Family

ID=26680118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002299 Ceased WO2001052817A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles

Country Status (5)

Country Link
EP (1) EP1259224A2 (fr)
JP (1) JP2003529557A (fr)
AU (1) AU3111401A (fr)
CA (1) CA2397792A1 (fr)
WO (1) WO2001052817A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219473A1 (en) * 2002-03-26 2003-11-27 Leila Zarif Cochleates made with purified soy phosphatidylserine
WO2004064805A1 (fr) * 2003-01-15 2004-08-05 Biodelivery Sciences International, Inc. Preparations cochleaires de nutriants fragiles
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP4789208B2 (ja) 2003-04-09 2011-10-12 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド タンパク質発現に向けられた渦巻型組成物
JP4627727B2 (ja) * 2003-10-15 2011-02-09 株式会社ナノエッグ 多価金属無機塩被覆レチノイン酸ナノ粒子含有組成物
JP4422681B2 (ja) * 2003-10-15 2010-02-24 株式会社ナノエッグ 多価金属無機塩被覆レチノイン酸ナノ粒子の製造方法および当該製造方法により得られたナノ粒子
WO2008070982A1 (fr) 2006-12-15 2008-06-19 National Research Council Of Canada Agrégats de lipides polaires d'archaea pour administration à des animaux
AU2012250568B2 (en) * 2011-05-05 2017-06-29 Matinas Biopharma Nanotechnologies, Inc. Cochleate compositions and methods of making and using same
EP3285874B1 (fr) * 2015-04-22 2021-03-17 Matinas BioPharma Nanotechnologies, Inc. Compositions et méthodes pour le traitement d'infections et de maladies pulmonaires à mycobactéries
AU2016280276A1 (en) * 2015-06-18 2017-12-07 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating inflammatory disease or conditions
KR20190029642A (ko) * 2016-07-12 2019-03-20 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 중추 신경계 전달 및 크립토코커스(cryptococcus) 감염의 치료를 위한 코클리에이트화된(encochleated) 항진균 화합물
KR101989789B1 (ko) * 2017-11-30 2019-06-18 (주) 에이치엔에이파마켐 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Also Published As

Publication number Publication date
JP2003529557A (ja) 2003-10-07
EP1259224A2 (fr) 2002-11-27
WO2001052817A2 (fr) 2001-07-26
AU3111401A (en) 2001-07-31
CA2397792A1 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
DK1143933T3 (da) Hidtil ukendte hydrogelisolerede cochleat-formuleringer, fremgangsmåde til fremstilling og deres anvendelse ved afgivelse af biologisk relevante molekyler
WO2001052817A3 (fr) Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
Evans et al. Thermodynamics of solution of nonpolar gases in a fused salt. Hydrophobic bonding behavior in a nonaqueous system
AU2001216127A1 (en) Foams containing functionalized metal oxide nanoparticles and methods of making same
EP1266959A3 (fr) Anlage und verfahren zur gewinnen von zellen
IL67939A0 (en) Production of pulverulent mixture of lipidic constituents and hydrophobic constituents,hydrated lipidic lamellar phases obtained therefrom and pharmaceutical and cosmetic composition comprising such phases
WO2003037835A3 (fr) Procede d'elimination d'impuretes polarisables contenues dans des hydrocarbures et melanges d'hydrocarbures
ES2130651T3 (es) Lipidos del tipo ceramida modificados con polietilenglicol y liposomas.
CN111991261B (zh) 一种适用于敏感头皮的温和控油洗发水组合物及其制备方法
CA2243946A1 (fr) Eau electrolytique reductrice et procede de preparation de celle-ci
WO2001083023A3 (fr) Acces percutane et transcutane a l'interieur du corps
WO2002018572A3 (fr) Peptides de penetration de membrane et utilisations associees
WO2000009086A3 (fr) Formulation protegee, dans un seul flacon, pour molecules d'acide nucleique, ses procedes de fabrication par melangeage en ligne, produits et procedes associes
ES2064048T3 (es) Inhibicion de incrustaciones.
WO1998020840A3 (fr) Preparations cosmetiques
AU2002340670A1 (en) Lipid carrier compositions and methods for improved drug retention
WO2003094865A1 (fr) Preparations externes pour la peau
Wang et al. Application of biosurfactants in medical sciences
ATE416751T1 (de) Kosmetisches und dermatologisches mittel mit magnetteilchen, dessen herstellung und verwendung
ATE330474T1 (de) Antimikrobielles mittel
IL174206A0 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
PT1177223E (pt) Dispersoes de plastico aquosas que apresentam uma estabilidade mais elevada
Fadnavis et al. Reverse micellar extraction of antibiotics from aqueous solutions
DE4036648A1 (de) Verwendung von insbesondere magnetischen vektorpotentialen zur behandlung von materialien
TW200516118A (en) Aqueous preparations of hydrophilic polyurethane resins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2397792

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 552865

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 31114/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001903273

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001903273

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001903273

Country of ref document: EP